What does MEDICAMA do?

MEDICAMA is a general practice in Saint-Ghislain. Private Limited, started on 23 December 1989.

What is the address of MEDICAMA?

The registered office of MEDICAMA is located at Rue Fosty(B) 6, 7331 Saint-Ghislain.

Is MEDICAMA still active?

Yes. According to the CBE (30 October 2026) MEDICAMA is active, legal situation “Normale toestand”, started on 23 December 1989.

Is MEDICAMA registered on Peppol?

Yes, MEDICAMA is registered on the Peppol network with ID 0208:0439607364.

What is the enterprise number of MEDICAMA?

The enterprise number of MEDICAMA is BE0439607364.

When was MEDICAMA founded?

MEDICAMA was founded on 23 December 1989.

Who are the directors of MEDICAMA?

According to the 2025 annual accounts, the directors of MEDICAMA are: Thierry MARCHAL.

Is MEDICAMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 December 1989; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDICAMA make in 2025?

MEDICAMA posted a profit after taxes of € 51,525 in financial year 2025.

What is the revenue of MEDICAMA?

As a small company, MEDICAMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 80,639.

MEDICAMA (Private Limited) - Saint-Ghislain

Dossier MEDICAMA, printed on 30 October 2026 from databakkes.be/en/0439607364/medicama. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDICAMA from Saint-Ghislain, company number BE0439607364, closed financial year 2025 with a result of € 51,525 after tax. For that financial year MEDICAMA recorded a gross margin of € 80,639 and equity of € 419,103. Compared with financial year 2024, the result moved from € 53,223 to € 51,525. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 1, 2026.

What it is worth Growing

€ 419,103

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 51,525

▼ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 205,230

▲ 48% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 833 paid out

2 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 9,454

▼ 37% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 820

▲ 15% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,224

▼ 16% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 98,295 Gross margin 2022: € 98,295 First fiscal year in the series	€ 68,019 Gross margin 2023: € 68,019 ▼ 31% vs 2022 (€ 98,295) Unfavourable step	€ 87,659 Gross margin 2024: € 87,659 ▲ 29% vs 2023 (€ 68,019) Favourable step	€ 80,639 Gross margin 2025: € 80,639 ▼ 8% vs 2024 (€ 87,659) Unfavourable step	▼ 8%
Profit after taxes	€ 49,112 Profit after taxes 2022: € 49,112 First fiscal year in the series	€ 37,419 Profit after taxes 2023: € 37,419 ▼ 24% vs 2022 (€ 49,112) Unfavourable step	€ 53,223 Profit after taxes 2024: € 53,223 ▲ 42% vs 2023 (€ 37,419) Favourable step	€ 51,525 Profit after taxes 2025: € 51,525 ▼ 3% vs 2024 (€ 53,223) Unfavourable step	▼ 3%
Equity	€ 287,768 Equity 2022: € 287,768 First fiscal year in the series	€ 325,188 Equity 2023: € 325,188 ▲ 13% vs 2022 (€ 287,768) Favourable step	€ 368,410 Equity 2024: € 368,410 ▲ 13% vs 2023 (€ 325,188) Favourable step	€ 419,103 Equity 2025: € 419,103 ▲ 14% vs 2024 (€ 368,410) Favourable step	▲ 14%
Total debts	€ 11,857 Total debts 2022: € 11,857 First fiscal year in the series	€ 2,350 Total debts 2023: € 2,350 ▼ 80% vs 2022 (€ 11,857) Favourable step	€ 13,504 Total debts 2024: € 13,504 ▲ € 11,155 vs 2023 (€ 2,350) Unfavourable step	€ 16,537 Total debts 2025: € 16,537 ▲ 22% vs 2024 (€ 13,504) Unfavourable step	▲ 22%
Cash	€ 257,365 Cash 2022: € 257,365 First fiscal year in the series	€ 75,683 Cash 2023: € 75,683 ▼ 71% vs 2022 (€ 257,365) Unfavourable step	€ 138,814 Cash 2024: € 138,814 ▲ 83% vs 2023 (€ 75,683) Favourable step	€ 205,230 Cash 2025: € 205,230 ▲ 48% vs 2024 (€ 138,814) Favourable step	▲ 48%
Land & buildings	€ 7,155 Land & buildings 2022: € 7,155 First fiscal year in the series	€ 9,639 Land & buildings 2023: € 9,639 ▲ 35% vs 2022 (€ 7,155) Unchanged	€ 8,130 Land & buildings 2024: € 8,130 ▼ 16% vs 2023 (€ 9,639) Unchanged	€ 6,622 Land & buildings 2025: € 6,622 ▼ 19% vs 2024 (€ 8,130) Unchanged	▼ 19%
Retained profit	€ 275,368 Retained profit 2022: € 275,368 First fiscal year in the series	€ 312,788 Retained profit 2023: € 312,788 ▲ 14% vs 2022 (€ 275,368) Favourable step	€ 356,010 Retained profit 2024: € 356,010 ▲ 14% vs 2023 (€ 312,788) Favourable step	€ 406,703 Retained profit 2025: € 406,703 ▲ 14% vs 2024 (€ 356,010) Favourable step	▲ 14%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 10,000 Dividend 2024: € 10,000 Unchanged (€ 0) Unchanged	€ 833 Dividend 2025: € 833 ▼ 92% vs 2024 (€ 10,000) Unchanged	▼ 92%
Balance sheet total	€ 299,625 Balance sheet total 2022: € 299,625 First fiscal year in the series	€ 327,537 Balance sheet total 2023: € 327,537 ▲ 9% vs 2022 (€ 299,625) Unchanged	€ 381,915 Balance sheet total 2024: € 381,915 ▲ 17% vs 2023 (€ 327,537) Unchanged	€ 435,640 Balance sheet total 2025: € 435,640 ▲ 14% vs 2024 (€ 381,915) Unchanged	▲ 14%

Key figures of MEDICAMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 May 2027.

What happened to MEDICAMA?

What happened at MEDICAMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 1, 2026 New annual accounts for financial year 2025: profit of € 51,525 (▼ 3% vs 2024). Source: NBB ↗
2026 Thierry MARCHAL stepped down as director. NBB
2020 Thierry MARCHAL became a director. NBB
Dec 23, 1989 Start of the company according to the CBE. KBO

In short

From € 49,112 profit in 2022 to € 51,525 profit in 2025.

Paid € 109,285 in corporate taxes since 2022.

Best year ever: 2024, with € 53,223 profit.

Paid out € 10,833 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Thierry MARCHAL

Director

since 2020 · until 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Fosty(B) 6

7331 Saint-Ghislain

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0439.607.364
VAT number: BE 0439.607.364
Registered office: Rue Fosty(B) 6, 7331 Saint-Ghislain
Names & denominations: MEDICAMA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 23 December 1989
Peppol: Active · Active since 1 Jan 2001
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDICAMA